Relaxed Stiffness of Lower Extremity Muscles and Step Width Variability as Key Differences Between Sarcopenia and...

Background and Objectives: Sarcopenia and muscle wasting contribute significantly to functional decline in older adults, but differences in lower extremity muscle stiffness and gait variability between these groups are not yet fully understood. This study aimed to compare gait variability, and lower extremity muscle stiffness during contraction and relaxation in community-dwelling older adults classified as non-diseased, sarcopenic, and dynapenic. Materials and Methods: This cross-sectional study included 164 community-dwelling older adults classified as non-diseased, dynapenic, or sarcopenic, based on handgrip strength, 5-time sit-to-stand test, and skeletal muscle index. Spatiotemporal gait variability was measured at the participants' preferred speed. Moreover, muscle thickness, as well as the contractile and relaxed stiffness, were measured for the rectus femoris (RF), biceps femoris (BF), tibialis anterior (TA), gastrocnemius medialis (GAmed), and lateralis (GAlat). Results: In dynapenic and sarcopenic groups, gait variability increased across most parameters, but only the step width coefficient of variation differed significantly between the dynapenic and sarcopenic groups. Contractile stiffness of the RF, BF, and GAlat was lower in both groups, with additional GAmed stiffness reduction in the sarcopenic group. Relaxed stiffness of the BF and GAmed was significantly higher in the sarcopenic group than in the dynapenic group. Conclusions: This study identified differences in muscle thickness, stiffness, and gait variability among non-diseased, dynapenic, and sarcopenic older adults. Step width variability, GAmed contractile stiffness, and BF and GAmed relaxed stiffness emerged as potential early indicators for distinguishing dynapenia from sarcopenia. These findings highlight the importance of assessing muscle quality-including both mass and stiffness characteristics-to better characterize early stages of age-related muscle decline and to inform targeted intervention strategies.